Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
It is a likely reason why the weight loss and liver fat numbers in trials look stronger than older single- or dual-pathway compounds
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors a mechanism distinct from semaglutide and tirzepatide
Because doses are so small, changes occur but
These findings support the continued development of retatrutide as a potential treatment option for type 2 diabetes, with ongoing phase 3 trials set to further evaluate its efficacy and safety
US$ 20.16
US$ 29.24
US$ 24.84
US$ 27.94
US$ 21.67
US$ 20.65
US$ 20.91
US$ 25.53
US$ 26.92
